U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07693166) titled 'Study of HIV-Exposed Pregnancies and Transplacental Antibody Delivery Following RSVpreF' on June 22.
Brief Summary: Respiratory syncytial virus (RSV) is the leading cause of hospitalization in young infants in Canada. While most babies recover, RSV can cause severe breathing problems and place major stress on families and the health system. Infants born to pregnant women and people with HIV, even if they do not acquire the virus, face higher risks of RSV illness. This is partly because HIV increases the chance of preterm birth and can reduce the amount of protective antibodies passed to the baby during pregnancy.
Two new tools now ...